GOLDMAN MYLA LAI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GOLDMAN MYLA LAI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GOLDMAN MYLA LAI. GOLDMAN MYLA LAI is EVP & Chief Medical Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Latest Insider Trading Transactions of GOLDMAN MYLA LAI
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 09 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | A | 75.63 | 46,700 | 3,531,921 | 46,700 | |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.59 | 100 | 7,259 | 22,660 | 22.8 K to 22.7 K (-0.44 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.60 | 500 | 36,300 | 22,760 | 23.3 K to 22.8 K (-2.15 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.61 | 200 | 14,522 | 23,260 | 23.5 K to 23.3 K (-0.85 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.80 | 100 | 7,280 | 23,460 | 23.6 K to 23.5 K (-0.42 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.85 | 200 | 14,570 | 23,560 | 23.8 K to 23.6 K (-0.84 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.86 | 300 | 21,858 | 23,760 | 24.1 K to 23.8 K (-1.25 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.87 | 200 | 14,574 | 24,060 | 24.3 K to 24.1 K (-0.82 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.88 | 100 | 7,288 | 24,260 | 24.4 K to 24.3 K (-0.41 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.90 | 900 | 65,610 | 24,360 | 25.3 K to 24.4 K (-3.56 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.91 | 800 | 58,328 | 25,260 | 26.1 K to 25.3 K (-3.07 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.92 | 700 | 51,044 | 26,060 | 26.8 K to 26.1 K (-2.62 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.93 | 400 | 29,172 | 26,760 | 27.2 K to 26.8 K (-1.47 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.94 | 573 | 41,795 | 27,160 | 27.7 K to 27.2 K (-2.07 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.97 | 200 | 14,594 | 27,733 | 27.9 K to 27.7 K (-0.72 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 72.99 | 800 | 58,392 | 27,933 | 28.7 K to 27.9 K (-2.78 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.00 | 400 | 29,200 | 28,733 | 29.1 K to 28.7 K (-1.37 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.01 | 600 | 43,806 | 29,133 | 29.7 K to 29.1 K (-2.02 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.02 | 737 | 53,816 | 29,733 | 30.5 K to 29.7 K (-2.42 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.03 | 263 | 19,207 | 30,470 | 30.7 K to 30.5 K (-0.86 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.04 | 300 | 21,912 | 30,733 | 31 K to 30.7 K (-0.97 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.05 | 200 | 14,610 | 31,033 | 31.2 K to 31 K (-0.64 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.06 | 200 | 14,612 | 31,233 | 31.4 K to 31.2 K (-0.64 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.07 | 600 | 43,842 | 31,433 | 32 K to 31.4 K (-1.87 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.08 | 200 | 14,616 | 32,033 | 32.2 K to 32 K (-0.62 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.09 | 200 | 14,618 | 32,233 | 32.4 K to 32.2 K (-0.62 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.12 | 100 | 7,312 | 32,433 | 32.5 K to 32.4 K (-0.31 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.13 | 100 | 7,313 | 32,533 | 32.6 K to 32.5 K (-0.31 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.14 | 600 | 43,884 | 32,633 | 33.2 K to 32.6 K (-1.81 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.17 | 200 | 14,634 | 33,233 | 33.4 K to 33.2 K (-0.60 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.19 | 200 | 14,638 | 33,433 | 33.6 K to 33.4 K (-0.59 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.20 | 400 | 29,280 | 33,633 | 34 K to 33.6 K (-1.18 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.22 | 800 | 58,576 | 34,033 | 34.8 K to 34 K (-2.30 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.23 | 100 | 7,323 | 34,833 | 34.9 K to 34.8 K (-0.29 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.24 | 200 | 14,648 | 34,933 | 35.1 K to 34.9 K (-0.57 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.25 | 100 | 7,325 | 35,133 | 35.2 K to 35.1 K (-0.28 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.27 | 200 | 14,654 | 35,233 | 35.4 K to 35.2 K (-0.56 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.28 | 600 | 43,968 | 35,433 | 36 K to 35.4 K (-1.67 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.29 | 300 | 21,987 | 36,033 | 36.3 K to 36 K (-0.83 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.30 | 1,100 | 80,630 | 36,333 | 37.4 K to 36.3 K (-2.94 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.31 | 300 | 21,993 | 37,433 | 37.7 K to 37.4 K (-0.80 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.32 | 200 | 14,664 | 37,733 | 37.9 K to 37.7 K (-0.53 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.34 | 100 | 7,334 | 37,933 | 38 K to 37.9 K (-0.26 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.35 | 400 | 29,340 | 38,033 | 38.4 K to 38 K (-1.04 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.36 | 900 | 66,024 | 38,433 | 39.3 K to 38.4 K (-2.29 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.37 | 300 | 22,011 | 39,333 | 39.6 K to 39.3 K (-0.76 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.38 | 100 | 7,338 | 39,633 | 39.7 K to 39.6 K (-0.25 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.39 | 300 | 22,017 | 39,733 | 40 K to 39.7 K (-0.75 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.40 | 700 | 51,380 | 40,033 | 40.7 K to 40 K (-1.72 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.41 | 200 | 14,682 | 40,733 | 40.9 K to 40.7 K (-0.49 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.42 | 500 | 36,710 | 40,933 | 41.4 K to 40.9 K (-1.21 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.45 | 200 | 14,690 | 41,433 | 41.6 K to 41.4 K (-0.48 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.47 | 600 | 44,082 | 41,633 | 42.2 K to 41.6 K (-1.42 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.48 | 600 | 44,088 | 42,233 | 42.8 K to 42.2 K (-1.40 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.49 | 105 | 7,716 | 42,833 | 42.9 K to 42.8 K (-0.24 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.50 | 100 | 7,350 | 42,938 | 43 K to 42.9 K (-0.23 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.51 | 400 | 29,404 | 43,038 | 43.4 K to 43 K (-0.92 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.52 | 200 | 14,704 | 43,438 | 43.6 K to 43.4 K (-0.46 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.53 | 500 | 36,765 | 43,638 | 44.1 K to 43.6 K (-1.13 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.54 | 300 | 22,062 | 44,138 | 44.4 K to 44.1 K (-0.68 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.55 | 400 | 29,420 | 44,438 | 44.8 K to 44.4 K (-0.89 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.58 | 795 | 58,496 | 44,838 | 45.6 K to 44.8 K (-1.74 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.60 | 200 | 14,720 | 45,633 | 45.8 K to 45.6 K (-0.44 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.64 | 400 | 29,456 | 45,833 | 46.2 K to 45.8 K (-0.87 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.65 | 500 | 36,825 | 46,233 | 46.7 K to 46.2 K (-1.07 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.66 | 300 | 22,098 | 46,733 | 47 K to 46.7 K (-0.64 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 74.02 | 100 | 7,402 | 47,033 | 47.1 K to 47 K (-0.21 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 74.50 | 18,052 | 1,344,874 | 47,133 | 65.2 K to 47.1 K (-27.69 %) |
| Mar 28 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 42,525 | 0 | 65,185 | 22.7 K to 65.2 K (+187.67 %) |
| Mar 05 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 77.00 | 971 | 74,767 | 22,660 | 23.6 K to 22.7 K (-4.11 %) |
| Mar 05 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 77.20 | 480 | 37,056 | 23,631 | 24.1 K to 23.6 K (-1.99 %) |
| Mar 05 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 77.55 | 160 | 12,408 | 24,111 | 24.3 K to 24.1 K (-0.66 %) |
| Mar 05 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 77.31 | 1,189 | 91,922 | 24,271 | 25.5 K to 24.3 K (-4.67 %) |
| Feb 27 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.10 | 300 | 23,730 | 25,460 | 25.8 K to 25.5 K (-1.16 %) |
| Feb 27 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.18 | 409 | 32,385 | 25,760 | 26.2 K to 25.8 K (-1.56 %) |
| Feb 27 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.25 | 602 | 47,709 | 26,169 | 26.8 K to 26.2 K (-2.25 %) |
| Feb 27 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.40 | 300 | 23,820 | 26,771 | 27.1 K to 26.8 K (-1.11 %) |
| Feb 27 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 79.29 | 1,189 | 94,276 | 27,071 | 28.3 K to 27.1 K (-4.21 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.50 | 200 | 15,900 | 28,260 | 28.5 K to 28.3 K (-0.70 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.51 | 311 | 24,728 | 28,460 | 28.8 K to 28.5 K (-1.08 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.52 | 100 | 7,952 | 28,771 | 28.9 K to 28.8 K (-0.35 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.60 | 300 | 23,880 | 28,871 | 29.2 K to 28.9 K (-1.03 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.75 | 300 | 23,925 | 29,171 | 29.5 K to 29.2 K (-1.02 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 400 | 32,000 | 29,471 | 29.9 K to 29.5 K (-1.34 %) |
| Feb 22 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 80.41 | 1,189 | 95,607 | 29,871 | 31.1 K to 29.9 K (-3.83 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.19 | 102 | 8,077 | 31,162 | 31.3 K to 31.2 K (-0.33 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.21 | 41 | 3,248 | 31,264 | 31.3 K to 31.3 K (-0.13 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.23 | 81 | 6,418 | 31,305 | 31.4 K to 31.3 K (-0.26 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.24 | 41 | 3,249 | 31,386 | 31.4 K to 31.4 K (-0.13 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.29 | 41 | 3,251 | 31,427 | 31.5 K to 31.4 K (-0.13 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.30 | 650 | 51,545 | 31,468 | 32.1 K to 31.5 K (-2.02 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.31 | 528 | 41,876 | 32,118 | 32.6 K to 32.1 K (-1.62 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.32 | 163 | 12,929 | 32,646 | 32.8 K to 32.6 K (-0.50 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.33 | 244 | 19,357 | 32,809 | 33.1 K to 32.8 K (-0.74 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.34 | 223 | 17,693 | 33,053 | 33.3 K to 33.1 K (-0.67 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.35 | 264 | 20,948 | 33,276 | 33.5 K to 33.3 K (-0.79 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.36 | 345 | 27,379 | 33,540 | 33.9 K to 33.5 K (-1.02 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.37 | 447 | 35,478 | 33,885 | 34.3 K to 33.9 K (-1.30 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.38 | 386 | 30,641 | 34,332 | 34.7 K to 34.3 K (-1.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.39 | 245 | 19,451 | 34,718 | 35 K to 34.7 K (-0.70 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.40 | 346 | 27,472 | 34,963 | 35.3 K to 35 K (-0.98 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.41 | 277 | 21,997 | 35,309 | 35.6 K to 35.3 K (-0.78 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.42 | 224 | 17,790 | 35,586 | 35.8 K to 35.6 K (-0.63 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.43 | 224 | 17,792 | 35,810 | 36 K to 35.8 K (-0.62 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.44 | 184 | 14,617 | 36,034 | 36.2 K to 36 K (-0.51 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.45 | 123 | 9,772 | 36,218 | 36.3 K to 36.2 K (-0.34 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.46 | 62 | 4,927 | 36,341 | 36.4 K to 36.3 K (-0.17 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.47 | 82 | 6,517 | 36,403 | 36.5 K to 36.4 K (-0.22 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.49 | 20 | 1,590 | 36,485 | 36.5 K to 36.5 K (-0.05 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.50 | 41 | 3,260 | 36,505 | 36.5 K to 36.5 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.51 | 41 | 3,260 | 36,546 | 36.6 K to 36.5 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.57 | 20 | 1,591 | 36,587 | 36.6 K to 36.6 K (-0.05 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.58 | 20 | 1,592 | 36,607 | 36.6 K to 36.6 K (-0.05 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.14 | 41 | 3,245 | 31,060 | 31.1 K to 31.1 K (-0.13 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.17 | 41 | 3,246 | 31,101 | 31.1 K to 31.1 K (-0.13 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.18 | 20 | 1,584 | 31,142 | 31.2 K to 31.1 K (-0.06 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.92 | 81 | 6,474 | 36,627 | 36.7 K to 36.6 K (-0.22 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.59 | 41 | 3,263 | 36,708 | 36.7 K to 36.7 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.61 | 41 | 3,264 | 36,749 | 36.8 K to 36.7 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.62 | 122 | 9,714 | 36,790 | 36.9 K to 36.8 K (-0.33 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.64 | 50 | 3,982 | 36,912 | 37 K to 36.9 K (-0.14 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.65 | 72 | 5,735 | 36,962 | 37 K to 37 K (-0.19 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.66 | 41 | 3,266 | 37,034 | 37.1 K to 37 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.68 | 81 | 6,454 | 37,075 | 37.2 K to 37.1 K (-0.22 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.70 | 81 | 6,456 | 37,156 | 37.2 K to 37.2 K (-0.22 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.72 | 122 | 9,726 | 37,237 | 37.4 K to 37.2 K (-0.33 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.74 | 61 | 4,864 | 37,359 | 37.4 K to 37.4 K (-0.16 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.75 | 122 | 9,730 | 37,420 | 37.5 K to 37.4 K (-0.32 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.76 | 81 | 6,461 | 37,542 | 37.6 K to 37.5 K (-0.22 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.77 | 41 | 3,271 | 37,623 | 37.7 K to 37.6 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.78 | 122 | 9,733 | 37,664 | 37.8 K to 37.7 K (-0.32 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.79 | 223 | 17,793 | 37,786 | 38 K to 37.8 K (-0.59 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.80 | 223 | 17,795 | 38,009 | 38.2 K to 38 K (-0.58 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.81 | 41 | 3,272 | 38,232 | 38.3 K to 38.2 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.82 | 61 | 4,869 | 38,273 | 38.3 K to 38.3 K (-0.16 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.83 | 142 | 11,336 | 38,334 | 38.5 K to 38.3 K (-0.37 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.84 | 122 | 9,740 | 38,476 | 38.6 K to 38.5 K (-0.32 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.85 | 122 | 9,742 | 38,598 | 38.7 K to 38.6 K (-0.32 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.87 | 41 | 3,275 | 38,720 | 38.8 K to 38.7 K (-0.11 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.90 | 81 | 6,472 | 38,761 | 38.8 K to 38.8 K (-0.21 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.93 | 81 | 6,474 | 38,842 | 38.9 K to 38.8 K (-0.21 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.96 | 20 | 1,599 | 38,923 | 38.9 K to 38.9 K (-0.05 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 79.98 | 110 | 8,798 | 38,943 | 39.1 K to 38.9 K (-0.28 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.09 | 183 | 14,656 | 39,053 | 39.2 K to 39.1 K (-0.47 %) |
| Feb 19 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 80.50 | 4,501 | 362,331 | 39,236 | 43.7 K to 39.2 K (-10.29 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 6,500 | 253,500 | 0 | |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 10,300 | 401,700 | 6,500 | |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 4,100 | 0 | 43,737 | 39.6 K to 43.7 K (+10.34 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 6,500 | 520,000 | 39,637 | 46.1 K to 39.6 K (-14.09 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 6,500 | 253,500 | 46,137 | 39.6 K to 46.1 K (+16.40 %) |